Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Research Report 2023

Publication ID:

PB502235872

Publication Date:

February 28, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Leveraging Cloud Computing in cell biology, genomics, and the drug development industry can help facilitate your research efforts to quickly and innovatively access clean, safe, and relevant data to find solutions to improve patient outcomes
Highlights
The global Cloud Computing in Cell Biology, Genomics and Drug Development market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cloud Computing in Cell Biology, Genomics and Drug Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cloud Computing in Cell Biology, Genomics and Drug Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cloud Computing in Cell Biology, Genomics and Drug Development in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cloud Computing in Cell Biology, Genomics and Drug Development include Google Inc., Amazon Web Services, Inc., IBM Corp., Oracle Corporation, Microsoft Corp., Arisglobal, Benchling, Box Inc and Cisco Systems, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cloud Computing in Cell Biology, Genomics and Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cloud Computing in Cell Biology, Genomics and Drug Development.
The Cloud Computing in Cell Biology, Genomics and Drug Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cloud Computing in Cell Biology, Genomics and Drug Development market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cloud Computing in Cell Biology, Genomics and Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Google Inc.
Amazon Web Services, Inc.
IBM Corp.
Oracle Corporation
Microsoft Corp.
Arisglobal
Benchling
Box Inc
Cisco Systems
Dell Emc
Cognizant
Dincloud
Exponential-e
Informatica
Segment by Type
Public Cloud
Private Cloud
Hybrid Cloud
Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Clinical Laboratories
Hospitals and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cloud Computing in Cell Biology, Genomics and Drug Development companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Public Cloud
1.2.3 Private Cloud
1.2.4 Hybrid Cloud
1.3 麻豆原创 by Application
1.3.1 Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Clinical Laboratories
1.3.5 Hospitals and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Perspective (2018-2029)
2.2 Cloud Computing in Cell Biology, Genomics and Drug Development Growth Trends by Region
2.2.1 Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cloud Computing in Cell Biology, Genomics and Drug Development Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Cloud Computing in Cell Biology, Genomics and Drug Development Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Dynamics
2.3.1 Cloud Computing in Cell Biology, Genomics and Drug Development Industry Trends
2.3.2 Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Drivers
2.3.3 Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Challenges
2.3.4 Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cloud Computing in Cell Biology, Genomics and Drug Development Players by Revenue
3.1.1 Global Top Cloud Computing in Cell Biology, Genomics and Drug Development Players by Revenue (2018-2023)
3.1.2 Global Cloud Computing in Cell Biology, Genomics and Drug Development Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cloud Computing in Cell Biology, Genomics and Drug Development Revenue
3.4 Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Concentration Ratio
3.4.1 Global Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cloud Computing in Cell Biology, Genomics and Drug Development Revenue in 2022
3.5 Cloud Computing in Cell Biology, Genomics and Drug Development Key Players Head office and Area Served
3.6 Key Players Cloud Computing in Cell Biology, Genomics and Drug Development Product Solution and Service
3.7 Date of Enter into Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cloud Computing in Cell Biology, Genomics and Drug Development Breakdown Data by Type
4.1 Global Cloud Computing in Cell Biology, Genomics and Drug Development Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Cloud Computing in Cell Biology, Genomics and Drug Development Forecasted 麻豆原创 Size by Type (2024-2029)
5 Cloud Computing in Cell Biology, Genomics and Drug Development Breakdown Data by Application
5.1 Global Cloud Computing in Cell Biology, Genomics and Drug Development Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Cloud Computing in Cell Biology, Genomics and Drug Development Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size (2018-2029)
6.2 North America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2018-2023)
6.4 North America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size (2018-2029)
7.2 Europe Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2018-2023)
7.4 Europe Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size (2018-2029)
9.2 Latin America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Cloud Computing in Cell Biology, Genomics and Drug Development 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Google Inc.
11.1.1 Google Inc. Company Detail
11.1.2 Google Inc. Business Overview
11.1.3 Google Inc. Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.1.4 Google Inc. Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.1.5 Google Inc. Recent Development
11.2 Amazon Web Services, Inc.
11.2.1 Amazon Web Services, Inc. Company Detail
11.2.2 Amazon Web Services, Inc. Business Overview
11.2.3 Amazon Web Services, Inc. Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.2.4 Amazon Web Services, Inc. Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.2.5 Amazon Web Services, Inc. Recent Development
11.3 IBM Corp.
11.3.1 IBM Corp. Company Detail
11.3.2 IBM Corp. Business Overview
11.3.3 IBM Corp. Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.3.4 IBM Corp. Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.3.5 IBM Corp. Recent Development
11.4 Oracle Corporation
11.4.1 Oracle Corporation Company Detail
11.4.2 Oracle Corporation Business Overview
11.4.3 Oracle Corporation Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.4.4 Oracle Corporation Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.4.5 Oracle Corporation Recent Development
11.5 Microsoft Corp.
11.5.1 Microsoft Corp. Company Detail
11.5.2 Microsoft Corp. Business Overview
11.5.3 Microsoft Corp. Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.5.4 Microsoft Corp. Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.5.5 Microsoft Corp. Recent Development
11.6 Arisglobal
11.6.1 Arisglobal Company Detail
11.6.2 Arisglobal Business Overview
11.6.3 Arisglobal Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.6.4 Arisglobal Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.6.5 Arisglobal Recent Development
11.7 Benchling
11.7.1 Benchling Company Detail
11.7.2 Benchling Business Overview
11.7.3 Benchling Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.7.4 Benchling Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.7.5 Benchling Recent Development
11.8 Box Inc
11.8.1 Box Inc Company Detail
11.8.2 Box Inc Business Overview
11.8.3 Box Inc Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.8.4 Box Inc Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.8.5 Box Inc Recent Development
11.9 Cisco Systems
11.9.1 Cisco Systems Company Detail
11.9.2 Cisco Systems Business Overview
11.9.3 Cisco Systems Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.9.4 Cisco Systems Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.9.5 Cisco Systems Recent Development
11.10 Dell Emc
11.10.1 Dell Emc Company Detail
11.10.2 Dell Emc Business Overview
11.10.3 Dell Emc Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.10.4 Dell Emc Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.10.5 Dell Emc Recent Development
11.11 Cognizant
11.11.1 Cognizant Company Detail
11.11.2 Cognizant Business Overview
11.11.3 Cognizant Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.11.4 Cognizant Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.11.5 Cognizant Recent Development
11.12 Dincloud
11.12.1 Dincloud Company Detail
11.12.2 Dincloud Business Overview
11.12.3 Dincloud Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.12.4 Dincloud Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.12.5 Dincloud Recent Development
11.13 Exponential-e
11.13.1 Exponential-e Company Detail
11.13.2 Exponential-e Business Overview
11.13.3 Exponential-e Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.13.4 Exponential-e Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.13.5 Exponential-e Recent Development
11.14 Informatica
11.14.1 Informatica Company Detail
11.14.2 Informatica Business Overview
11.14.3 Informatica Cloud Computing in Cell Biology, Genomics and Drug Development Introduction
11.14.4 Informatica Revenue in Cloud Computing in Cell Biology, Genomics and Drug Development Business (2018-2023)
11.14.5 Informatica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Google Inc.
Amazon Web Services, Inc.
IBM Corp.
Oracle Corporation
Microsoft Corp.
Arisglobal
Benchling
Box Inc
Cisco Systems
Dell Emc
Cognizant
Dincloud
Exponential-e
Informatica

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.